Profilo
Sondra S.
Newman is currently the Global Head-Investor Relations at Repligen Corp.
Prior to this, she worked as the Director-Investor Relations at NitroMed, Inc.
Posizioni attive di Sondra S. Newman
| Società | Posizione | Inizio |
|---|---|---|
| REPLIGEN CORPORATION | Investor Relations Contact | - |
Precedenti posizioni note di Sondra S. Newman
| Società | Posizione | Fine |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
- Borsa valori
- Insiders
- Sondra S. Newman
